Skip to the main content.

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

The Ophthalmology Contract Research Organization for Innovators

An End-to-End Partner to Accelerate Your Visionary Device from Concept to Clinical Reality.

The Only Ophthalmology Innovation Contract Research Organization (iCRO) to Conquer the Market Hurdles 

Bringing a novel ophthalmic device to market requires navigating a series of significant and interconnected hurdles.

eyeball
01

Gaining market approval is a primary challenge. High-risk devices requiring Premarket Approval (PMA) face an intensive process, with an average cost of $94 million spent on FDA-required activities alone.

02

Demonstrating safety and efficacy is paramount. A single medical device clinical trial can cost between $5 and $10 million and often requires years of follow-up to prove long-term outcomes.

03

The adoption of advanced technology is limited by a growing physician shortage. By 2035, the U.S. is projected to see a 12% decrease in ophthalmologists while demand surges by 24%.

The Solution

Integrated Ophthalmology Contract Research Organization for Innovation

From initial market insight to final clinical validation, we provide the integrated expertise to accelerate your path to market.

Ensure market success by designing what clinicians and patients actually need  

Our teams gather first-hand insights from ophthalmologists, surgical support staff, and patients to define the critical user needs that drive successful product design and development.

Research & Strategy

op-1

Build a durable competitive advantage in the crowded ophthalmology market 

We deliver comprehensive market assessments, pricing analyses, and reimbursement strategies to create a clear, data-driven roadmap for commercial success and investor confidence.

Commercialization

op-2

Strategically navigate complex global regulatory landscapes

With a 96% FDA submission clearance rate, our regulatory experts develop the least-burdensome strategy for FDA and EU MDR approvals.

Regulatory Services

op-3

Custom anatomical testing models to de-risk development

Custom test models that simulate clinical condition ensures your device performs as intended with the correct evaluation to guide development or use for design verification. 

Testing & Prototyping

op-4

Traceable, high-quality builds from prototype to human trial

We provide controlled manufacturing for your devices in our ISO Class 8 cleanrooms and BSL-2 biohazard lab spaces, ensuring they are ready for preclinical studies and clinical use. 

Manufacturing

op-5

Generate critical safety and performance data with studies designed for clinical relevance

Support with non-GLP, GLP, preclinical training, and histology services for your ophthalmic device. We collaborate directly with consulting ophthalmologists to ensure our preclinical study designs will deliver the most meaningful and translatable outcomes for your specific device.

Preclinical Services

op-6

Execute complex ophthalmic trials designed for successful submission and market adoption

Our global, device-focused CRO excels at managing the unique challenges of ophthalmology trials—from long-term patient follow-up to generating the health economic evidence required for reimbursement.

Clinical Services

op-7

Our Depth of Experience Across Ophthalmic Medical Devices

From retinal implants to advanced drug delivery, our teams have partnered on some of the industry's most complex challenges.

op-slied-1

Ophthalmic Therapy Segment: Retinal Disease / Vision Restoration

  • Wearable Vision System (External Glasses + Implant)
  • We have developed the external smart glasses component and conducted the human factors research for a complex system designed to treat blindness caused by retinitis pigmentosa.
op-slide-2

Ophthalmic Therapy Segment: Glaucoma / Minimally Invasive Glaucoma Surgery (MIGS)

  • Surgical Implantation Device
  • We engineered a unique, ergonomic "pencil grip" implantation device for placing intraocular stents, prioritizing the exceptional control and safety required for delicate glaucoma surgery.
op-slide-3

Ophthalmic Therapy Segment: Advanced Drug Delivery

  • Microdosing Drug Delivery Platform
  • We developed a platform drug delivery technology capable of administering a precise micro-dose to the cornea faster than the human blink reflex, suitable for treating conditions like childhood myopia and macular edema.
op-slide-4

Ophthalmic Therapy Segment: Cataract Surgery

  • Surgical Implantation Tool
  • Our teams have engineered precision intraocular lens (IOL) insertion tools to improve the safety and efficiency of cataract procedures.
op-slide-5

Ophthalmic Therapy Segment: Neurological Vision / Vision Restoration

  • Human Factors & Imaging Analysis
  • We have conducted extensive human factors research and imaging analysis to guide the precise surgical placement of novel visual cortex implants.
op-slide-6

Ophthalmic Therapy Segment: Surgical Training & Preclinical Research

  • Preclinical Surgical Models & Physician Training
  • We have deep experience developing preclinical surgical models for conditions like glaucoma and keratoconjunctivitis. We facilitate physician training for complex procedures such as retinal device implantation and subretinal drug delivery, utilizing our state-of-the-art equipment, including a Leica M820 surgical microscope and a Stellaris vitrectomy machine.
Section5_Cataract and Refractive Surgery_AdobeStock_1088242288

Ophthalmic Therapy Segment: Cataract and Refractive Surgery

  • Surgical Platforms & Digital Health Integration
  • We have extensive experience providing market access, health economics (time and motion studies), and commercial strategy for market-leading surgical suites. This includes femtosecond laser platforms, 3D visualization systems, and the digital health software that connects them to optimize clinical workflow.  
Section5_Diagnostics Surgical Planning_AdobeStock_1525119003

Ophthalmic Therapy Segment: Diagnostics & Surgical Planning

  • Biometers & Diagnostic Platforms 
  • We have supported diagnostic platforms with clinical research, reimbursement strategies, and the development of health economic models and value communication tools to demonstrate their impact on practice efficiency. 
Section5_Retinal Disease Glaucoma_AdobeStock_80096395

Ophthalmic Therapy Segment: Retinal Disease & Glaucoma

  • Advanced IOLs, Drug-Eluting Technologies, & Cell Therapies 
  • Our work includes developing reimbursement landscapes and payer value propositions for a wide range of advanced technologies, including drug-eluting IOLs, surgical devices for AMD, glaucoma drainage devices, and novel cell therapies for both front and back-of-the-eye applications. 
Section5_Diagnostics General Eye Care_AdobeStock_646831589

Ophthalmic Therapy Segment: Diagnostics & General Eye Care

  • Diagnostic & Refractometry Devices 
  • For manufacturers of high-quality diagnostic devices, we have provided comprehensive regulatory and quality support, including 510(k) submissions, QMS updates, and cleanroom and sterilization validation.  
Section5_Surgical Assistance_AdobeStock_272263671

Ophthalmic Therapy Segment: Surgical Assistance

  • Assistive Surgical Robotics 
  • We have partnered with pioneers in ophthalmic robotics, providing crucial regulatory strategy assessments and guidance for FDA pre-submission meetings to support the development of their revolutionary platforms. 
Section5_Diagnostics Digital Health_AdobeStock_1241112286

Ophthalmic Therapy Segment: Diagnostics & Digital Health

  • AI-Powered Remote Retinal Imaging 
  • We have provided US FDA regulatory assessment support for a de novo digital health platform that uses AI and remote retinal imaging to screen for various disease states. 
Section5_Retinal Disease_AdobeStock_29125584

Ophthalmic Therapy Segment: Retinal Disease

  • Advanced Drug Delivery Systems 
  • For companies specializing in nanotechnology and microelectromechanical systems for drug delivery to the retina, we have provided critical quality support, including Design History File (DHF) updates and risk management.  

The Ophthalmology Contract Research Organization That Will Turn Vision into Velocity.

Navigating the complex challenges from early design planning through clinical trials.